Journal
Frontiers in Oncology
Publication Date
1-1-2022
Volume
12
First Page
978996
Document Type
Open Access Publication
DOI
10.3389/fonc.2022.978996
Rights and Permissions
Khaddour K, Zhou A, Butt OH, Budde G, Malashevich AK and Ansstas G (2022) Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios. Front. Oncol. 12:978996. doi: 10.3389/fonc.2022.978996 © 2022 Khaddour, Zhou, Butt, Budde, Malashevich and Ansstas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Khaddour, Karam; Zhou, Alice; Butt, Omar H; Budde, Griffin; Malashevich, Allyson Koyen; and Ansstas, George, "Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios." Frontiers in Oncology. 12, 978996 (2022).
https://digitalcommons.wustl.edu/oa_4/2444
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
